Genentech Oncology
Investigational Therapies
These compounds and their uses are investigational and have not been approved by the US Food and Drug Administration. Efficacy and safety have not been established. The information presented should not be construed as a recommendation for use. The relevance of findings in preclinical studies to humans is currently being evaluated.
Showing 58 out of 58 results
Phase III
Breast
Gastrointestinal
Genitourinary
Hematology
Lung
Phase II
Gastrointestinal
Head Neck
Hematology
Lung
Solid Tumor
Phase I
Brain
Breast
Gastrointestinal
Hematology
Solid Tumor
aDeveloped in collaboration with Array Biopharma.bDeveloped in collaboration with Exelixis. cJoint project with AbbVie. dDeveloped in collaboration with Xencor.
Current as of May 10, 2022. The trial information is taken from ClinicalTrials.gov.
-
-
Roche. 2022 Q1 results. April 25, 2022. Accessed May 10, 2022. https://www.roche.com/investors/updates/inv-update-2022-04-25
Roche. 2022 Q1 results. April 25, 2022. Accessed May 10, 2022. https://www.roche.com/investors/updates/inv-update-2022-04-25
-
-
The content on this website is intended for US healthcare professionals only.
The compounds and their uses mentioned on this website are investigational and have not been approved by the US Food and Drug Administration. Efficacy and safety have not been established. The information presented should not be construed as a recommendation for use. Do you wish to proceed?